Annual accounts receivable:
$241.39M+$22.93M(+10.49%)Summary
- As of today (May 31, 2025), TECH annual accounts receivable is $241.39 million, with the most recent change of +$22.93 million (+10.49%) on June 30, 2024.
- During the last 3 years, TECH annual accounts receivable has risen by +$96.01 million (+66.04%).
- TECH annual accounts receivable is now at all-time high.
Performance
TECH Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$237.14M+$19.20M(+8.81%)Summary
- As of today (May 31, 2025), TECH quarterly accounts receivable is $237.14 million, with the most recent change of +$19.20 million (+8.81%) on March 31, 2025.
- Over the past year, TECH quarterly accounts receivable has increased by +$9.25 million (+4.06%).
- TECH quarterly accounts receivable is now -1.76% below its all-time high of $241.39 million, reached on June 30, 2024.
Performance
TECH Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TECH Accounts receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +10.5% | +4.1% |
3 y3 years | +66.0% | +17.3% |
5 y5 years | +75.6% | +101.9% |
TECH Accounts receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +66.0% | -1.8% | +36.1% |
5 y | 5-year | at high | +97.0% | -1.8% | +101.9% |
alltime | all time | at high | +1418.8% | -1.8% | +1524.8% |
TECH Accounts receivable History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $237.14M(+8.8%) |
Dec 2024 | - | $217.94M(-2.6%) |
Sep 2024 | - | $223.69M(-7.3%) |
Jun 2024 | $241.39M(+10.5%) | $241.39M(+5.9%) |
Mar 2024 | - | $227.89M(+9.9%) |
Dec 2023 | - | $207.45M(+1.4%) |
Sep 2023 | - | $204.57M(-6.4%) |
Jun 2023 | $218.47M(+12.3%) | $218.47M(+0.9%) |
Mar 2023 | - | $216.41M(+17.1%) |
Dec 2022 | - | $184.76M(+6.1%) |
Sep 2022 | - | $174.17M(-10.5%) |
Jun 2022 | $194.55M(+33.8%) | $194.55M(-3.7%) |
Mar 2022 | - | $202.09M(+32.2%) |
Dec 2021 | - | $152.90M(+3.6%) |
Sep 2021 | - | $147.55M(+1.5%) |
Jun 2021 | $145.38M(+18.6%) | $145.38M(-7.9%) |
Mar 2021 | - | $157.79M(+23.0%) |
Dec 2020 | - | $128.24M(+4.6%) |
Sep 2020 | - | $122.64M(+0.1%) |
Jun 2020 | $122.53M(-10.9%) | $122.53M(+4.3%) |
Mar 2020 | - | $117.45M(+5.1%) |
Dec 2019 | - | $111.75M(-8.9%) |
Sep 2019 | - | $122.72M(-10.7%) |
Jun 2019 | $137.47M(+14.3%) | $137.47M(+2.6%) |
Mar 2019 | - | $133.93M(+18.2%) |
Dec 2018 | - | $113.28M(-1.3%) |
Sep 2018 | - | $114.75M(-4.6%) |
Jun 2018 | $120.30M(+3.0%) | $120.30M(+9.6%) |
Mar 2018 | - | $109.76M(+11.4%) |
Dec 2017 | - | $98.50M(-8.2%) |
Sep 2017 | - | $107.33M(-8.1%) |
Jun 2017 | $116.83M(+25.1%) | $116.83M(-1.3%) |
Mar 2017 | - | $118.33M(+13.4%) |
Dec 2016 | - | $104.37M(-5.0%) |
Sep 2016 | - | $109.81M(+17.6%) |
Jun 2016 | $93.39M(+33.4%) | $93.39M(+7.2%) |
Mar 2016 | - | $87.16M(+31.8%) |
Dec 2015 | - | $66.14M(-6.7%) |
Sep 2015 | - | $70.92M(+1.3%) |
Jun 2015 | $70.03M(+27.3%) | $70.03M(+6.3%) |
Mar 2015 | - | $65.89M(+15.2%) |
Dec 2014 | - | $57.21M(-6.0%) |
Sep 2014 | - | $60.87M(+10.7%) |
Jun 2014 | $55.00M(+44.0%) | $55.00M(+13.4%) |
Mar 2014 | - | $48.50M(+26.6%) |
Dec 2013 | - | $38.31M(-9.3%) |
Sep 2013 | - | $42.24M(+10.6%) |
Jun 2013 | $38.18M | $38.18M(+0.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2013 | - | $38.14M(+18.5%) |
Dec 2012 | - | $32.19M(-8.3%) |
Sep 2012 | - | $35.12M(-1.5%) |
Jun 2012 | $35.67M(-0.7%) | $35.67M(-8.8%) |
Mar 2012 | - | $39.11M(+20.9%) |
Dec 2011 | - | $32.35M(-5.1%) |
Sep 2011 | - | $34.09M(-5.1%) |
Jun 2011 | $35.91M(+16.4%) | $35.91M(+1.0%) |
Mar 2011 | - | $35.55M(+26.0%) |
Dec 2010 | - | $28.23M(-9.0%) |
Sep 2010 | - | $31.02M(+0.5%) |
Jun 2010 | $30.85M(+4.5%) | $30.85M(-10.6%) |
Mar 2010 | - | $34.53M(+32.0%) |
Dec 2009 | - | $26.16M(-13.8%) |
Sep 2009 | - | $30.33M(+2.8%) |
Jun 2009 | $29.52M(-7.0%) | $29.52M(-6.6%) |
Mar 2009 | - | $31.59M(+27.1%) |
Dec 2008 | - | $24.85M(-23.0%) |
Sep 2008 | - | $32.30M(+1.7%) |
Jun 2008 | $31.75M(+7.4%) | $31.75M(-3.2%) |
Mar 2008 | - | $32.80M(+12.0%) |
Dec 2007 | - | $29.27M(-4.6%) |
Sep 2007 | - | $30.67M(+3.8%) |
Jun 2007 | $29.56M(+24.4%) | $29.56M(-0.1%) |
Mar 2007 | - | $29.58M(+29.0%) |
Dec 2006 | - | $22.92M(-6.3%) |
Sep 2006 | - | $24.47M(+2.9%) |
Jun 2006 | $23.77M(+7.8%) | $23.77M(-8.7%) |
Mar 2006 | - | $26.02M(+23.8%) |
Dec 2005 | - | $21.02M(-6.4%) |
Sep 2005 | - | $22.46M(+1.9%) |
Jun 2005 | $22.04M(+8.8%) | $22.04M(-4.3%) |
Mar 2005 | - | $23.02M(+22.5%) |
Dec 2004 | - | $18.80M(+0.5%) |
Sep 2004 | - | $18.71M(-7.6%) |
Jun 2004 | $20.26M(+10.2%) | $20.26M(-1.5%) |
Mar 2004 | - | $20.56M(+21.3%) |
Dec 2003 | - | $16.95M(-5.3%) |
Sep 2003 | - | $17.90M(-2.6%) |
Jun 2003 | $18.39M(+8.7%) | $18.39M(-1.9%) |
Mar 2003 | - | $18.73M(+26.0%) |
Dec 2002 | - | $14.87M(-11.1%) |
Sep 2002 | - | $16.71M(-1.2%) |
Jun 2002 | $16.91M(+6.4%) | $16.91M(-1.4%) |
Mar 2002 | - | $17.15M(+17.5%) |
Dec 2001 | - | $14.60M(-11.1%) |
Sep 2001 | - | $16.41M(+3.2%) |
Jun 2001 | $15.89M | $15.89M(+5.0%) |
Mar 2001 | - | $15.14M |
FAQ
- What is Bio-Techne annual accounts receivable?
- What is the all time high annual accounts receivable for Bio-Techne?
- What is Bio-Techne annual accounts receivable year-on-year change?
- What is Bio-Techne quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Bio-Techne?
- What is Bio-Techne quarterly accounts receivable year-on-year change?
What is Bio-Techne annual accounts receivable?
The current annual accounts receivable of TECH is $241.39M
What is the all time high annual accounts receivable for Bio-Techne?
Bio-Techne all-time high annual accounts receivable is $241.39M
What is Bio-Techne annual accounts receivable year-on-year change?
Over the past year, TECH annual accounts receivable has changed by +$22.93M (+10.49%)
What is Bio-Techne quarterly accounts receivable?
The current quarterly accounts receivable of TECH is $237.14M
What is the all time high quarterly accounts receivable for Bio-Techne?
Bio-Techne all-time high quarterly accounts receivable is $241.39M
What is Bio-Techne quarterly accounts receivable year-on-year change?
Over the past year, TECH quarterly accounts receivable has changed by +$9.25M (+4.06%)